The New England Journal of Medicine,
Whether the addition of pembrolizumab to standard first-line chemotherapy improves outcomes in patients with advanced…
Pembrolizumab plus Chemotherapy in Advanced Endometrial Cancer
Overview of attention for article published in New England Journal of Medicine, March 2023
Altmetric Badge
About this Attention Score
-
In the top 5% of all research outputs scored by Altmetric
-
High Attention Score compared to outputs of the same age (99th percentile)
-
High Attention Score compared to outputs of the same age and source (88th percentile)
Mentioned by
- news
- 81 news outlets
- blogs
- 2 blogs
- policy
- 1 policy source
- 331 X users
- patent
- 1 patent
- 1 Facebook page
- wikipedia
- 4 Wikipedia pages
- 2 Redditors
- video
- 1 YouTube creator
- guideline
- 10 clinical guideline sources
- podcasts
- 3 podcasts
Readers on
- mendeley
- 400 Mendeley